Elevated serum IL-23 correlates with intraocular inflammation after cataract surgery in patients with Vogt-Koyanagi-Harada disease

British Journal of Ophthalmology

Volumn 94, Issue 8, 2010, Pages 1078-1082

  Jiang, Shuhong ^a   Liu, Xialin ^a   Luo, Lixia ^a   Qu, Bo ^a   Huang, Xiangkun ^a   Xu, Li ^a,b   Lin, Ying ^a   Ye, Shaobi ^a   Liu, Yizhi ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b INNER MONGOLIA MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 27;

ADULT; AQUEOUS HUMOR; ARTICLE; CATARACT EXTRACTION; CELL COUNT; CLINICAL ARTICLE; CONGENITAL CATARACT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE INFLAMMATION; FEMALE; HELPER CELL; HUMAN; LASER FLARE CELL METER; MALE; POSTOPERATIVE INFLAMMATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; UPREGULATION; VOGT KOYANAGI SYNDROME;

ADULT; AQUEOUS HUMOR; CATARACT; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-23; MALE; MIDDLE AGED; PANUVEITIS; PHACOEMULSIFICATION; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 77955254027     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.169052     Document Type: Article

References (23)

1. Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 1995;39:265-92.
2. Yang P, Ren Y, Li B, et al. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology 2007;114:606-14.
3. Moorthy RS, Rajeev B, Smith RE, et al. Incidence and management of cataracts in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 1994;118:197-204.
4. Amadi-Obi A, Yu CR, Liu X, et al. Th17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 2007;13:711-18.
5. Wilson NJ, Boniface K, Chan JR, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007;8:950-7.
6. Chi W, Yang P, Li B, et al. IL-23 promotes CD4+ Tcells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol 2007;119:1218-24.
7. Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001;131:647-52.
8. Liu Y, Luo L, He M, et al. Disorders of the bloode-queous barrier after phacoemulsification in diabetic patients. Eye 2004;18:900-4.
9. Fang W, Zhou H, Yang P, et al. Longitudinal quantification of aqueous flare and cells in Vogt-Koyanagi-Harada disease. Br J Ophthalmol 2008;92:182-5.
10. Rubsamen PE, Gass JD. Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol 1991;109:682-7.
11. Rauz S, Stavrou P, Murray PI. Evaluation of foldable intraocular lens in patients with uveitis. Ophthalmology 2000;107:909-19.
12. Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000;13:715-25.
13. Cua DJ, Sherlock J, Chen Y, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003;421:744-8.
14. Chi W, Zhu X, Yang P, et al. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Invest Ophthalmol Vis Sci 2008;49:3058-64.
15. Liu X, Yang P, Lin X, et al. Inhibitory effect of cyclosporin A and corticosteroids on the production of IFN-gamma and IL-17 by T cells in Vogt-Koyanagi-Harada syndrome. Clin Immunol 2009;131:333-42.
16. Yang K, Wen J, Liu X, et al. Inhibitory effect of rapamycin and dexamethasone on production of IL-17 and IFN-gamma in Vogt-Koyanagi-Harada patients. Br J Ophthalmol 2009;93:249-53.
17. Batten M, Li J, Yi S, et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 2006;7:929-36.
18. Murugaiyan G, Mittal A, Lopez-Diego R, et al. IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J Immunol 2009;183:2435-43.
19. Luger D, Caspi RR. New perspectives on effector mechanisms in uveitis. Semin Immunopathol 2008;30:135-43.
20. Luger D, Silver PB, Tang J, et al. Either a Th17 or a Th1 effector response can drive autoimmunity: context of initial Ag exposure determines dominant effector category. J Exp Med 2008;205:799-810.
21. Banerjee S, Savant V, Scott RA, et al. Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders. Invest Ophthalmol Vis Sci 2007;48:2203-7.
22. Tu KL, Kaye SB, Sidaras G, et al. Effect of intraocular surgery and ketamine on aqueous and serum cytokines. Mol Vis 2007;13:1130-7.
23. Wallace GR, Farmer I, Church A, et al. Serum levels of chemokines correlate with disease activity in patients with retinal vasculitis. Immunol Lett 2003;90:59-64.